Oops! Something went wrong while submitting the form.
Introducing CLAW
Meet CLAW - the tokenization of the Percepta IP-NFT, a project that raised over $500,000 for research development. Join our mission to combat memory loss and cognitive decline through groundbreaking innovation and community-driven research.
Percepta® is a patent-protected brain health natural dietary supplement (active ingredients, PTI-00703® Cat’s claw and MemorTea® - a specific oolong tea extract). Cerebrum DAO will be supporting the development of near- and long-term solutions for targeting cognitive decline, memory loss and neurodegenerative diseases.
Percepta has the potential to be the category leader in this fast growing $8.6b market with human evidence to support outcomes and the funding of future studies that could lead to FDA botanical drug status which is the ultimate goal.
What is CLAW?
CLAW is an IP-Token (IPT) that represents fractional governance rights over the intellectual property portfolio tied to the NEURON-Percepta IP-NFT. CLAW allows qualifying community members (CLAW IPT holders) to participate in the governance of this groundbreaking project. The CLAW token represents a world’s first tokenization of a robust patent portfolio and a world’s first tokenized crowdsale for a clinical evidence study.
The CLAW Story
Cerebrum DAO partnered with Cognitive Clarity Inc. to validate Percepta®’s groundbreaking results in reducing amyloid plaques and tau tangles.
October 1, 2024
The Percepta® funding application is submitted
October 8, 2024
Funding for Percepta® Replication Study is approved via IP-NFT by $NEURON token holders
December 2, 2024
CLAW - the first neuroscience IPT - is developed. Public sale is announced.
December 18, 2024
Funding Secured! CerebrumDAO has successfully tokenized the IP-NFT, Percepta®, and raised $300K+
CLAW Tokenomics
IP Tokens represent membership in an IP pool containing the IP and R&D data attached to their parent IP-NFT. The IP Tokens of the Percepta® IP-NFT are denoted by the token symbol $CLAW. The rights of Percepta-IPT token holders are governed by the IPT Membership Agreement.
CLAW Catalyst Sale
Open Sale
63
%
CerebrumDAO
37
%
Backed by Science. Powered by Community.
Cerebrum DAO partnered with Cognitive Clarity Inc. to validate Percepta®’s groundbreaking results in reducing amyloid plaques and tau tangles.
This website uses cookies to improve your browsing experience. Please read our Privacy Policy for more information on what data we gather and how it is used.
